Ethyl 1-(3-formylpyridin-2-yl)piperidine-4-carboxylate

Catalog No.: 
ACLKVG302
CAS No.: 
886361-48-4
Molecular Formula: 
C14H18N2O3
Molecular Weight: 
262.31
Ethyl 1-(3-formylpyridin-2-yl)piperidine-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg95%$353.00InquiryInquiry
250mg95%$555.00InquiryInquiry
1g95%$728.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 1-(3-formylpyridin-2-yl)piperidine-4-carboxylate
IUPAC Nameethyl 1-(3-formylpyridin-2-yl)piperidine-4-carboxylate
Molecular FormulaC14H18N2O3
Molecular Weight262.31
SMILESO=C(C1CCN(C2=NC=CC=C2C=O)CC1)OCC
InChI KeyNTDVMWNLFAJSAS-UHFFFAOYSA-N
SynonymETHYL 1-(3-FORMYL-2-PYRIDINYL)-4-PIPERIDINECARBOXYLATE;4-Piperidinecarboxylic acid, 1-(3-formyl-2-pyridinyl)-, ethyl ester
CAS No.886361-48-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLKVG302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEXNQ621 route compound structure diagram
    ACEXNQ621147636-76-8In Stock
  2. Plus
  3. ACNRTH015 route compound structure diagram
    ACNRTH01536404-88-3In Stock
  4. Then
  5. ACLKVG302 route product structure diagram
    ACLKVG302886361-48-4
Inquiry

2. ACLKVG302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLKVG302 route product structure diagram
    ACLKVG302886361-48-4
Inquiry

3. ACLKVG302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLKVG302 route product structure diagram
    ACLKVG302886361-48-4
Inquiry

Comments (0)